Strategic Roadmap and Financial Performance
(1)
Healthcare Platform | Sukoon
Revenue | SAR MN (1)
86.6
84.7
20.1
20.9
Financial and Operational Review | Period Ended 31st March 2022
Financial Performance
4% year-on-year growth in revenue, driven by favorable patient mix, with higher volumes of acuity
patients, more than offsetting a marginal decline in census due to the ongoing facility expansion works
SAR 2.7MN of EBITDA delivered in 1Q-2022, up from SAR 2.2MN in the same period last year, driven
by revenue increases and effective cost management increasing margin to 13% vs. 11% in the prior
year
Facility renovation works to expand bed capacity by c100 beds in progress
FY20
FY21
1Q21
1Q22
EBITDA | SAR MN (1)
Net Cash (Debt)
SAR 91.6 MN
✓ Completed Initiative
Action Plan
12.1%
11.0% 13.0%
10.2
2.2
(63.8)
FY20
FY21
1Q21
EBITDA Margin
Net Profit | SAR MN (1)
2.7
Corporate
Strategy
1Q22
Corporate
Finance
31 Mar. 2022
• Ongoing Initiative
✓ Complete facility redesign and renovation to improve patient flow and increase capacity
Complete Phase 1 of facility renovation by 2Q22
Introduce new service lines such as homecare and training programs
→ Diversify client base and contract with new payors
Implement new ERP system
→ Fund facility renovation and growth plans from available cash and internally generated funds,
explore additional sources of funding as required
0.8
0.0
✓
Maintain JCI accreditation
(0.9)
Corporate
Governance
✓ Maintain CBAHI accreditation
(78.2)
FY20
FY21
1Q21
1Q22
Includes one-off items of SAR 54.3 MN in FY20
✓ Develop financial and operational KPIs to track Management performance
20View entire presentation